{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:18:07Z","timestamp":1745986687540,"version":"3.40.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial Science and Technology Plan Project of Sichuan Provincial Department of Science and Technology"},{"name":"Sichuan Provincial Health Commission Science and Technology Project (Suitable Technology Base)"},{"name":"Clinical Research Fund for Western Stomatology of the Chinese Stomatological Association"},{"name":"Project of Sichuan Provincial Administration of Traditional Chinese Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02464-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:23:04Z","timestamp":1745940184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of anlotinib hydrochloride on the expression of immunogenic cell death-related molecules in Cal27 tongue cancer cells"],"prefix":"10.1007","volume":"16","author":[{"given":"Pengcheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"1","key":"2464_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12885-024-11954-y","volume":"24","author":"A Almangush","year":"2024","unstructured":"Almangush A, Hagstr\u00f6m J, Haglund C, Kowalski LP, Coletta RD, M\u00e4kitie AA, Salo T, Leivo I. The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma. BMC Cancer. 2024;24(1):213. https:\/\/doi.org\/10.1186\/s12885-024-11954-y.","journal-title":"BMC Cancer"},{"issue":"1","key":"2464_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.oraloncology.2017.02.015","volume":"67","author":"OF Karatas","year":"2017","unstructured":"Karatas OF, Oner M, Abay A, et al. MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications. Oral Oncol. 2017;67(1):124\u201330.","journal-title":"Oral Oncol"},{"issue":"1","key":"2464_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41368-024-00302-2","volume":"16","author":"C Xie","year":"2024","unstructured":"Xie C, Zhong L, Feng H, et al. Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis. Int J Oral Sci. 2024;16(1):48. https:\/\/doi.org\/10.1038\/s41368-024-00302-2.","journal-title":"Int J Oral Sci"},{"issue":"12","key":"2464_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306515","volume":"11","author":"Y Zhi","year":"2024","unstructured":"Zhi Y, Wang Q, Zi M, et al. Spatial transcriptomic and metabolomic landscapes of oral submucous fibrosis-derived oral squamous cell carcinoma and its tumor microenvironment. Adv Sci (Weinh). 2024;11(12): e2306515. https:\/\/doi.org\/10.1002\/advs.202306515.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"2464_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","volume":"18","author":"DG Pfister","year":"2020","unstructured":"Pfister DG, Spencer S, Adelstein D, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(7):873\u201398. https:\/\/doi.org\/10.6004\/jnccn.2020.0031.","journal-title":"J Natl Compr Canc Netw"},{"key":"2464_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105921","volume":"76","author":"M Wang","year":"2019","unstructured":"Wang M, Zhao L, Tong D, et al. BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma. Int Immunopharmacol. 2019;76: 105921. https:\/\/doi.org\/10.1016\/j.intimp.2019.105921.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2464_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.659","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang X, Xue X, Pang M, et al. Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm (2020). 2024;5(8): e659. https:\/\/doi.org\/10.1002\/mco2.659.","journal-title":"MedComm (2020)"},{"issue":"19","key":"2464_CR8","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.3390\/cancers13194756","volume":"13","author":"R Kim","year":"2021","unstructured":"Kim R, Kin T. Current and future therapies for immunogenic cell death and related molecules to potentially cure primary breast cancer. Cancers (Basel). 2021;13(19):4756\u201380.","journal-title":"Cancers (Basel)"},{"issue":"52","key":"2464_CR9","doi-asserted-by":"publisher","first-page":"e1904914","DOI":"10.1002\/adma.201904914","volume":"31","author":"C Chen","year":"2019","unstructured":"Chen C, Ni X, Jia S, et al. Massively evoking immunogenic cell death by focused mitochondrial oxidative stress using an AIE luminogen with a twisted molecular structure. Adv Mater. 2019;31(52):e1904914\u201324.","journal-title":"Adv Mater"},{"issue":"8","key":"2464_CR10","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/jcmm.14356","volume":"23","author":"J Zhou","year":"2019","unstructured":"Zhou J, Wang G, Chen Y, et al. Immunogenic cell death in cancer therapy: present and emerging inducers. J Cell Mol Med. 2019;23(8):4854\u201365.","journal-title":"J Cell Mol Med"},{"issue":"I","key":"2464_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(I):110\u201327.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"2464_CR12","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.18632\/oncotarget.14425","volume":"8","author":"M Ogawa","year":"2017","unstructured":"Ogawa M, Tomita Y, Nakamura Y, et al. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget. 2017;8(6):10425\u201336.","journal-title":"Oncotarget"},{"issue":"1","key":"2464_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","volume":"21","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi L, Kepp O, Hett E, et al. Immunogenic cell death in cancer: concept and therapeutic implications. J Transl Med. 2023;21(1):162.","journal-title":"J Transl Med"},{"issue":"1\u20133","key":"2464_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1387\/ijdb.150061pa","volume":"59","author":"AD Garg","year":"2015","unstructured":"Garg AD, Dudek-Peric AM, Romano E, et al. Immunogenic cell death. Int J Dev Biol. 2015;59(1\u20133):131\u201340.","journal-title":"Int J Dev Biol"},{"issue":"1","key":"2464_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/igc.0000000000001129","volume":"28","author":"S Taurin","year":"2018","unstructured":"Taurin S, Yang CH, Reyes M, et al. Endometrial cancers harboring mutated fibroblast growth factor receptor 2 protein are successfully treated with a new small tyrosine kinase inhibitor in an orthotopic mouse model. Int J Gynecol Cancer. 2018;28(1):152\u201360.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2464_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","volume":"15","author":"DS Ettinger","year":"2017","unstructured":"Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(4):504\u201335.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"11","key":"2464_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jamaoncol.2018.3039","volume":"4","author":"B Han","year":"2018","unstructured":"Han B, Kai L, Wang Q, et al. Effect of Anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the alter 0303 phase 3 randomized clinical trial. JAMA Oncol. 2018;4(11):1569\u201375.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2464_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-020-01721-x","volume":"21","author":"Z Deng","year":"2021","unstructured":"Deng Z, Liao W, Wei W, et al. Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe. Cancer Cell Int. 2021;21(1):37\u201345.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"2464_CR19","doi-asserted-by":"publisher","first-page":"618931","DOI":"10.3389\/fbioe.2020.618931","volume":"8","author":"M Zhang","year":"2020","unstructured":"Zhang M, Liang J, Yang Y, et al. Current trends of targeted drug delivery for oral cancer therapy. Front Bioeng Biotechnol. 2020;8(8):618931\u201341.","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"2464_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","volume":"8","author":"TS Lau","year":"2020","unstructured":"Lau TS, Chan LKY, Man GCW, Wong CH, Lee JHS, Yim SF, Cheung TH, McNeish IA, Kwong J. Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4\/IKK2\/SNARE-dependent exocytosis. Cancer Immunol Res. 2020;8(8):1099\u2013111. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0616.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2464_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imr.12582","volume":"280","author":"N Bloy","year":"2017","unstructured":"Bloy N, Garcia P, Laumont CM, et al. Immunogenic stress and death of cancer cells: contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunol Rev. 2017;280(1):165\u201374. https:\/\/doi.org\/10.1111\/imr.12582.","journal-title":"Immunol Rev"},{"issue":"91","key":"2464_CR22","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1039\/d1cc04604g","volume":"57","author":"Y Li","year":"2021","unstructured":"Li Y, Liu X, Zhang X, Pan W, Li N, Tang B. Immunogenic cell death inducers for enhanced cancer immunotherapy. Chem Commun (Camb). 2021;57(91):12087\u201397. https:\/\/doi.org\/10.1039\/d1cc04604g.","journal-title":"Chem Commun (Camb)"},{"issue":"4","key":"2464_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/cells10040930","volume":"10","author":"R Vaes","year":"2021","unstructured":"Vaes R, Hendriks L, Vooijs M, et al. Biomarkers of radiotherapy-induced immunogenic cell death. Cells. 2021;10(4):930\u201345.","journal-title":"Cells"},{"issue":"1","key":"2464_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","volume":"31","author":"J Fucikova","year":"2021","unstructured":"Fucikova J, Spisek R, Kroemer G, et al. Calreticulin and cancer. Cell Res. 2021;31(1):5\u201316. https:\/\/doi.org\/10.1038\/s41422-020-0383-9.","journal-title":"Cell Res"},{"key":"2464_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.mie.2019.05.011","volume":"632","author":"P Liu","year":"2020","unstructured":"Liu P, Zhao L, Kepp O, Kroemer G. Quantitation of calreticulin exposure associated with immunogenic cell death. Methods Enzymol. 2020;632:1\u201313. https:\/\/doi.org\/10.1016\/bs.mie.2019.05.011.","journal-title":"Methods Enzymol"},{"issue":"4","key":"2464_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbrc.2019.03.192","volume":"513","author":"A Syy","year":"2019","unstructured":"Syy A, Wen R, Stc E, et al. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate. Biochem Biophys Res Commun. 2019;513(4):891\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"36","key":"2464_CR27","doi-asserted-by":"publisher","first-page":"24443","DOI":"10.18632\/oncotarget.25325","volume":"9","author":"E Turrini","year":"2018","unstructured":"Turrini E, Catanzaro E, Muraro MG, et al. Hemidesmus indicus induces immunogenic death in human colorectal cancer cells. Oncotarget. 2018;9(36):24443\u201356.","journal-title":"Oncotarget"},{"issue":"7","key":"2464_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jgg.2021.06.014","volume":"48","author":"Z Huang","year":"2021","unstructured":"Huang Z, Su Q, Li W, et al. Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma. J Genet Genomics. 2021;48(7):582\u201394.","journal-title":"J Genet Genomics"},{"key":"2464_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.lungcan.2021.03.018","volume":"3","author":"R Furukawa","year":"2021","unstructured":"Furukawa R, Inoue H, Yoneshima Y, et al. Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non\u2013small cell lung cancer. Lung Cancer. 2021;3:144\u201350.","journal-title":"Lung Cancer"},{"issue":"20","key":"2464_CR30","doi-asserted-by":"publisher","first-page":"755433","DOI":"10.3389\/fonc.2021.755433","volume":"11","author":"F Scirocchi","year":"2021","unstructured":"Scirocchi F, Napoletano C, Pace A, et al. Immunogenic cell death and immunomodulatory effects of cabozantinib. Front Oncol. 2021;11(20):755433\u201344.","journal-title":"Front Oncol"},{"issue":"4","key":"2464_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.11817\/j.issn.1672-7347.2022.210679","volume":"47","author":"J Xu","year":"2022","unstructured":"Xu J, Tao P, L\u00fc D, et al. Role of high-mobility group box 1 in cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(4):505\u201311. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2022.210679. (English, Chinese).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"2464_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00262-017-2109-5","volume":"67","author":"CY Huang","year":"2018","unstructured":"Huang CY, Chiang SF, Ke TW, et al. Cytosolic high-mobility group box protein 1 (hmgb1) and\/or pd-1+ tils in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy. Cancer Immunol Immunother. 2018;67(4):551\u201362.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"2464_CR33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.7518\/hxkq.2020.05.005","volume":"38","author":"QZ Sun","year":"2020","unstructured":"Sun QZ, Shi F, Luo D, et al. Thermo-chemotherapy enhances the immunogenicity of oral squamous cell carcinoma cells by inducing the expression of damage-associated molecular patterns. Hua Xi Kou Qiang Yi Xue Za Zhi. 2020;38(5):502\u20138. https:\/\/doi.org\/10.7518\/hxkq.2020.05.005. (Chinese).","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"issue":"4","key":"2464_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-021-03605-y","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zheng J, Chen S, et al. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer. Cell Death Dis. 2021;12(4):314. https:\/\/doi.org\/10.1038\/s41419-021-03605-y.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2464_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13046-019-1275-z","volume":"38","author":"M Cirone","year":"2019","unstructured":"Cirone M, GilardiniMontani MS, Granato M, et al. Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences. J Exp Clin Cancer Res. 2019;38(1):262. https:\/\/doi.org\/10.1186\/s13046-019-1275-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"2464_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-021-03605-y","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zheng J, Chen S, et al. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer. Cell Death Dis. 2021;12(4):314\u201328.","journal-title":"Cell Death Dis"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02464-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:23:08Z","timestamp":1745940188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02464-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02464-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as the research conducted in this study did not involve direct interactions with human subjects or the collection of primary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read the journal guidelines and agreed to consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"639"}}